<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="letter" dtd-version="2.3" xml:lang="EN" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><front>
<journal-meta><journal-id journal-id-type="publisher-id">SCIENCE</journal-id><journal-title>Science</journal-title><abbrev-journal-title abbrev-type="pubmed">Science</abbrev-journal-title><issn pub-type="ppub">0036-8075</issn><issn pub-type="epub">1095-9203</issn>
<publisher>
<publisher-name>American Association for the Advancement of Science</publisher-name>
</publisher>
</journal-meta>
<article-meta><article-categories>
<subj-group subj-group-type="article-type"><subject>Letter</subject></subj-group>
<subj-group subj-group-type="heading"><subject>Letters</subject></subj-group>
<subj-group subj-group-type="legacy-article-type"><subject>letters</subject></subj-group>
</article-categories>
<title-group>
<article-title>A Global Perspective on HIV/AIDS</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Saxena</surname><given-names>Shailendra K.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<contrib contrib-type="author"><name><surname>Tiwari</surname><given-names>Sneham</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Nair</surname><given-names>Madhavan P. N.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib>
<aff id="aff1"><label>1</label>CSIR-Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad 500007 (AP), India.</aff>
<aff id="aff2"><label>2</label>College of Medicine, Florida International University, Miami, fl33199, USA.</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>To whom correspondence should be addressed. E-mail: <email>shailen@ccmb.res.in</email></corresp>
</author-notes><pub-date pub-type="ppub">
<day>17</day>
<month>08</month>
<year>2012</year>
</pub-date><volume>337</volume><issue>6096</issue><fpage>798</fpage><lpage>798</lpage><permissions>
<copyright-statement>Copyright &#x00A9; 2012, American Association for the Advancement of Science</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder>American Association for the Advancement of Science</copyright-holder>
</permissions>
<self-uri xlink:title="pdf" xlink:href="letters.pdf" /><custom-meta-wrap>
<custom-meta><meta-name>Editor</meta-name><meta-value>Jennifer Sills</meta-value></custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>The special section on HIV/AIDS in America (13 July, p. <related-article related-article-type="in-this-publication" vol="337" page="167" issue="6091">167</related-article>) did not explicitly deal with the variations in HIV subtypes and their implications. HIV-1 is phylogenetically divided into three distinct groups&#x2014;M, N, O (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>)&#x2014;and subtype/clade&#x2014;A to K. HIV-1B, found predominantly in the United States and Europe, is the most studied subtype, even though it represents only about 12% of worldwide infections (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>). Of the 34 million HIV-1&#x2013;infected people in the world, about 48% suffer from HIV-1C (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>, <xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). By discussing HIV/AIDS in America, we indirectly focus on HIV-1B, when we should be making HIV-1C a priority.</p>
<fig id="F1" position="float">
<caption>
<title>AIDS in India.</title>
<p>An HIV-positive mother of two sits in the women's AIDS ward of Tambaram Hospital.</p>
</caption>
<graphic xlink:href="337_798_F1" />
<attrib>CREDIT: MALCOLM LINTON</attrib>
</fig>
<p>HIV-1C has caused millions of deaths. According to the UNAIDS, currently there are about 34 million people living with HIV, including 2.7 million cases of new infection and 1.8 million deaths in 2010 alone. The majority of the cases and deaths were in HIV-1C&#x2013;prevalent regions (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>, <xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). However, the true number is likely even higher. Data are underreported because of lack of resources, illiteracy, and ignorance in developing countries, which make statistical and sampling studies of the patients living in core rural areas almost impossible. Associated conditions, such as HIV-associated dementia (HAD), which is apparently more common and severe in HIV-1B patients (<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>) than those with HIV-1C (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>, <xref ref-type="bibr" rid="R7"><italic>7</italic></xref>), may also be underreported. The low incidence of HAD in HIV-1C&#x2013;affected regions such as India, China, and sub-Saharan Africa may be attributable to under-diagnosis due to social stigma, inadequate medical facilities, ignorance, shorter life expectancy, short survival after HIV infection, discordance in clinical prevalence of various opportunistic infections, lack of enough autopsy reports, various host and genetic factors, and abuse of drugs (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>, <xref ref-type="bibr" rid="R9"><italic>9</italic></xref>).</p>
<p>Our understanding and treatment of HIV-1B may not apply to HIV-1C. There are substantial differences in HIV-1B and HIV-1C viruses, including variation in sequences, structure, antigenic variance, glycosylation, and other interactions (<xref ref-type="bibr" rid="R10"><italic>10</italic></xref>), which collectively result in different replication kinetics and immune responses (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>, <xref ref-type="bibr" rid="R11"><italic>11</italic></xref>). In our experience, successful therapeutic strategies in the United States are more specific for the HIV-1B virus and may not be suitable for HIV-1C patients. The &#x201C;treatment cascade&#x201D; (<xref ref-type="bibr" rid="R12"><italic>12</italic></xref>), which quantifies the actual number of patients receiving treatment out of the total number of HIV patients, shows that the treatment is not available to all who need it in HIV-1C&#x2013;prevalent, low-income countries.</p>
<p>HIV-1C infection is rapidly spreading to Europe and America (<xref ref-type="bibr" rid="R13"><italic>13</italic></xref>). Collaborative international projects and interclade HIV research programs may provide a better vision for clade-specific diversity, opening enhanced avenues for developing therapeutics against HIV/AIDS globally. These programs may help to extend preventive services and treatment to all populations in need.</p>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="R1">
<label>1</label>
<citation citation-type="web">
<collab collab-type="author">Centers for Disease Control and Prevention</collab>, <source>&#x201C;Screening for HIV infection during the refugee domestic medical examination&#x201D;</source> (<publisher-name>CDC</publisher-name>, <day>16</day>
<month>April</month>
<year>2012</year>); <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/screening-hiv-infection-domestic.html">www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/screening-hiv-infection-domestic.html</ext-link>.</citation>
</ref>
<ref id="R2">
<label>2</label>
<citation citation-type="web">
<collab collab-type="author">World Health Organization&#x2013;UNAIDS</collab>, <source>&#x201C;UNAIDS World AIDS Day Report 2011&#x201D;</source> (<ext-link ext-link-type="uri" xlink:href="http://www.who.int/hiv/data/2011_epi_core_en.pps">www.who.int/hiv/data/2011_epi_core_en.pps</ext-link>).</citation>
</ref>
<ref id="R3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author"><name><surname>Hemelaar</surname><given-names>J.</given-names></name></person-group>, <source>Trends Mol. Med.</source>
<volume>18</volume>, <fpage>182</fpage> (<year>2012</year>).</citation>
</ref>
<ref id="R4">
<label>4</label>
<citation citation-type="web">
<collab collab-type="author">UNAIDS</collab>, <source>&#x201C;Report on the global AIDS epidemic 2010,&#x201D;</source>
<comment>chap. 2</comment> (<ext-link ext-link-type="uri" xlink:href="http://www.unaids.org/documents/20101123_GlobalReport_Chap2_em.pdf">www.unaids.org/documents/20101123_GlobalReport_Chap2_em.pdf</ext-link>).</citation>
</ref>
<ref id="R5">
<label>5</label>
<citation citation-type="web">
<collab collab-type="author">National Institute of Mental Health</collab>, <source>&#x201C;Viral genetic underpinnings of HIV-associated dementia explored&#x201D;</source> (<comment>Science Update</comment>, <day>9</day>
<month>October</month>
<year>2008</year>); <ext-link ext-link-type="uri" xlink:href="http://www.nimh.nih.gov/science-news/2008/viral-genetic-underpinnings-of-hiv-associated-dementia-explored.shtml">www.nimh.nih.gov/science-news/2008/viral-genetic-underpinnings-of-hiv-associated-dementia-explored.shtml</ext-link>.</citation>
</ref>
<ref id="R6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author"><name><surname>Samikkannu</surname><given-names>T.</given-names></name><etal/></person-group>., <source>J. Neurovirol.</source>
<volume>16</volume>, <fpage>255</fpage> (<year>2010</year>).</citation>
</ref>
<ref id="R7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author"><name><surname>Saxena</surname><given-names>S. K.</given-names></name><etal/></person-group>., <source>Nanomedicine (London)</source>
<volume>7</volume>, <fpage>941</fpage> (<year>2012</year>).</citation>
</ref>
<ref id="R8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author"><name><surname>Gandhi</surname><given-names>N.</given-names></name><etal/></person-group>., <source>J. Neurovirol.</source>
<volume>16</volume>, <fpage>294</fpage> (<year>2010</year>).</citation>
</ref>
<ref id="R9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author"><name><surname>Reddy</surname><given-names>P. V.</given-names></name><etal/></person-group>., <source>AIDS Res. Treat.</source>
<volume>2012</volume>, <fpage>953678</fpage> (<year>2012</year>).</citation>
</ref>
<ref id="R10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author"><name><surname>Saiyed</surname><given-names>Z. M.</given-names></name><etal/></person-group>., <source>Neurochem. Int.</source>
<volume>58</volume>, <fpage>656</fpage> (<year>2011</year>).</citation>
</ref>
<ref id="R11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author"><name><surname>Sundaravaradan</surname><given-names>V.</given-names></name><etal/></person-group>., <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>103</volume>, <fpage>11701</fpage> (<year>2006</year>).</citation>
</ref>
<ref id="R12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J.</given-names></name></person-group>, <source>Science</source>
<volume>337</volume>, <fpage>168</fpage> (<year>2012</year>).</citation>
</ref>
<ref id="R13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author"><name><surname>Gandhi</surname><given-names>N.</given-names></name><etal/></person-group>., <source>AIDS Res. Hum. Retroviruses</source>
<volume>25</volume>, <fpage>691</fpage> (<year>2009</year>).</citation>
</ref>
</ref-list>
</back>
</article>
